Quoin Pharmaceuticals, Ltd. (NasdaqCM: QNRX)
Health Care · Biotechnology · US
$3.90
-13.33% today · -76.2% 1Y
Quoin Pharmaceuticals, Ltd. (NasdaqCM: QNRX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $18.74M and employs 4 people.
Over the last twelve months the share price has lost 76.2%, trading between 3.25 and 23.50.
Tweenvest scores Quoin Pharmaceuticals, Ltd. across four factors: quality 35/100, value 85/100. Its strongest factor is value.
QNRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.74M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -8.52
- Dividend yield
- —
- Beta (5Y)
- 1.74
- 52-week high
- $23.50
- 52-week low
- $3.25
- Avg volume (3M)
- —
- Shares outstanding
- 4.80M
- Employees
- 4
- Next earnings
- —
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
- ISIN
- US74907L4095
- Founded
- 2018
- Listed since
- Aug 1, 2016
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| GenSight Biologics S.A.ENXTPA: SIGHT | $19.05M | €0.07 | -5.00% |
| HST Global, Inc.OTCPK: HSTC | $18.91M | $0.13 | -80.90% |
| Dextech Medical ABXSAT: DEX | $18.89M | Skr— | — |
| General Biologicals CorporationTPEX: 4117 | $18.79M | NT$8.61 | -8.31% |
| Estrella Immunopharma, Inc.NasdaqCM: ESLA | $18.70M | $0.43 | +4.88% |
| Akari Therapeutics, PlcNasdaqCM: AKTX | $18.69M | $8.18 | -6.73% |
| Kyntra Bio, Inc.NasdaqGS: KYNB | $18.55M | $4.58 | -12.26% |
| Defence Therapeutics Inc.CNSX: DTC | $18.22M | CA$0.34 | -15.00% |
Figures last refreshed Oct 18, 2026.